Published in Blood Weekly, October 30th, 2003
"Multiple myeloma is a non-curable hematological disease involving transformed plasma cells," scientists in Germany explained. "High rates of complete remission can be achieved with autologous peripheral blood stem-cell transplantation."
"Treosulfan is an alkylating substance that has been used in the treatment of ovarian carcinomas for many years," and "has a favorable side-effect profile even at high-dose protocols," noted G. Meinhardt and colleagues at the University of Muenchen Hospital. They conducted a study "to evaluate the effect of treosulfan on myeloma cells."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.